-transparent.png){kind=logo}
The in vitro effect of pirprofen (Rengasil), an antiinflammatory agent, on the surface ultrastructure and function of human platelets was examined and compared with that of acetylsalicylic acid (Aspirin, ASA), and diclofenac sodium (Voltaren, DS). Incubation with pirprofen induced formation of long, needle-shaped pseudopodia, a phenomenon observed also after incubation of the cells with DS. In contrast with ASA and DS, pirprofen induced a marked increase in platelet protein synthesizing capacity. The drug decreased the platelet aggregation to a degree similar to that of ASA and DS. The release of platelet factors 3 and 4 and the level of beta-thromboglobulin following incubation with the drug remained unaltered.
M Djaldetti, and
R Gilgal, and
D Creter, and
I Zahavi
January 1988,
Lasers in surgery and medicine,
M Djaldetti, and
R Gilgal, and
D Creter, and
I Zahavi
April 1987,
Singapore medical journal,
M Djaldetti, and
R Gilgal, and
D Creter, and
I Zahavi
February 1982,
Cryobiology,
M Djaldetti, and
R Gilgal, and
D Creter, and
I Zahavi
November 1969,
The Indian journal of medical research,
M Djaldetti, and
R Gilgal, and
D Creter, and
I Zahavi
January 1977,
Haemostasis,
M Djaldetti, and
R Gilgal, and
D Creter, and
I Zahavi
January 1987,
International journal of tissue reactions,
M Djaldetti, and
R Gilgal, and
D Creter, and
I Zahavi
July 1969,
Nature,
M Djaldetti, and
R Gilgal, and
D Creter, and
I Zahavi
January 1993,
Platelets,
M Djaldetti, and
R Gilgal, and
D Creter, and
I Zahavi
September 2005,
Thrombosis and haemostasis,
M Djaldetti, and
R Gilgal, and
D Creter, and
I Zahavi
March 2023,
Annals of translational medicine,
